Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

January 01, 1989; Volume 35,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderson, D

    1. You have access
      Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;

B

  1. Balfour, C

    1. You have access
      Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;
  2. Beer, B

    1. You have access
      Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
  3. Beyer, C F

    1. You have access
      Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. You have access
      Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;
  4. Blume, A J

    1. You have access
      Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. You have access
      Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;
  5. Burstein, S H

    1. You have access
      Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;

C

  1. Cheung, A H

    1. You have access
      Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;
  2. Correia, M A

    1. You have access
      Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;
  3. Cox, R F

    1. You have access
      Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
      R F Cox and B L Waszczak
      Molecular Pharmacology January 1989, 35 (1) 125-131;
  4. Criscione, K R

    1. You have access
      Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;
  5. Czajkowski, C

    1. You have access
      Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;

D

  1. Dawson, G

    1. You have access
      Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;
  2. Dixon, R A

    1. You have access
      Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;

F

  1. Farb, D H

    1. You have access
      Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;
  2. Fine, J S

    1. You have access
      Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;
  3. Fischer, P H

    1. You have access
      Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;
  4. Ford, J M

    1. You have access
      Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;
  5. Francel, P C

    1. You have access
      Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;

G

  1. Gasiewicz, T A

    1. You have access
      Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;
  2. Gibbs, T T

    1. You have access
      Transmembrane topology of the gamma-aminobutyric acidA/benzodiazepine receptor: subcellular distribution and allosteric coupling determined in situ.
      C Czajkowski, T T Gibbs and D H Farb
      Molecular Pharmacology January 1989, 35 (1) 75-84;
  3. Girard, P R

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;
  4. Gistrak, M A

    1. You have access
      Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;
  5. Gnegy, M E

    1. You have access
      Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
      P H Roseboom and M E Gnegy
      Molecular Pharmacology January 1989, 35 (1) 139-147;
  6. Grunewald, G L

    1. You have access
      Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;

H

  1. Hahn, E F

    1. You have access
      Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;
  2. Hait, W N

    1. You have access
      Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;
  3. Halpert, J

    1. You have access
      Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;
  4. Hirsch, J D

    1. You have access
      Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. You have access
      Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;
  5. Hoffman, B B

    1. You have access
      Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
      J M Thomas and B B Hoffman
      Molecular Pharmacology January 1989, 35 (1) 116-124;
  6. Hsu, A H

    1. You have access
      Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;
  7. Hull, K

    1. You have access
      Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;
  8. Hunter, S A

    1. You have access
      Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;
  9. Hwang, S B

    1. You have access
      Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;

I

  1. Itzhak, Y

    1. You have access
      Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;

J

  1. Jaw, J Y

    1. You have access
      Specific inactivation by 17 beta-substituted steroids of rabbit and rat liver cytochromes P-450 responsible for progesterone 21-hydroxylation.
      J Halpert, J Y Jaw and C Balfour
      Molecular Pharmacology January 1989, 35 (1) 148-156;

K

  1. Karlsson, M O

    1. You have access
      Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
      M O Karlsson and A Neil
      Molecular Pharmacology January 1989, 35 (1) 59-66;
  2. Keefer, J F

    1. You have access
      Bradykinin analogs antagonize bradykinin-induced second messenger production in a sensory neuron cell line.
      P C Francel, J F Keefer and G Dawson
      Molecular Pharmacology January 1989, 35 (1) 34-38;
  3. Klein, M

    1. You have access
      Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;
  4. Kunugi, K

    1. You have access
      Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;
  5. Kuo, J F

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

L

  1. Lam, M H

    1. You have access
      Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
      S B Hwang, M H Lam and A H Hsu
      Molecular Pharmacology January 1989, 35 (1) 48-58;
  2. Loullis, C C

    1. You have access
      Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;
  3. Lunetta, J M

    1. You have access
      Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;

M

  1. Malkowitz, L

    1. You have access
      Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control.
      J D Hirsch, C F Beyer, L Malkowitz, B Beer and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 157-163;
    2. You have access
      Characterization of ligand binding to mitochondrial benzodiazepine receptors.
      J D Hirsch, C F Beyer, L Malkowitz, C C Loullis and A J Blume
      Molecular Pharmacology January 1989, 35 (1) 164-172;
  2. McKinney, M

    1. You have access
      Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;
  3. Musacchio, J M

    1. You have access
      Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;

N

  1. Neil, A

    1. You have access
      Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
      M O Karlsson and A Neil
      Molecular Pharmacology January 1989, 35 (1) 59-66;
  2. Ng, D S

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;

P

  1. Parente, J E

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;
  2. Pasternak, G W

    1. You have access
      Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;
  3. Paturzo, J J

    1. You have access
      Effects of dextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine.
      J M Musacchio, M Klein and J J Paturzo
      Molecular Pharmacology January 1989, 35 (1) 1-5;
  4. Price, M

    1. You have access
      Receptor binding of [3H]naloxone benzoylhydrazone: a reversible kappa and slowly dissociable mu opiate.
      M Price, M A Gistrak, Y Itzhak, E F Hahn and G W Pasternak
      Molecular Pharmacology January 1989, 35 (1) 67-74;
  5. Prozialeck, W C

    1. You have access
      Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance.
      J M Ford, W C Prozialeck and W N Hait
      Molecular Pharmacology January 1989, 35 (1) 105-115;

R

  1. Roseboom, P H

    1. You have access
      Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
      P H Roseboom and M E Gnegy
      Molecular Pharmacology January 1989, 35 (1) 139-147;

S

  1. Sall, D J

    1. You have access
      Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;
  2. Shilstone, J

    1. You have access
      Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
      S H Burstein, K Hull, S A Hunter and J Shilstone
      Molecular Pharmacology January 1989, 35 (1) 6-9;
  3. Sigal, I S

    1. You have access
      Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;
  4. Silverstone, A E

    1. You have access
      Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      J S Fine, T A Gasiewicz and A E Silverstone
      Molecular Pharmacology January 1989, 35 (1) 18-25;
  5. Strader, C D

    1. You have access
      Agonist-promoted sequestration of the beta 2-adrenergic receptor requires regions involved in functional coupling with Gs.
      A H Cheung, I S Sigal, R A Dixon and C D Strader
      Molecular Pharmacology January 1989, 35 (1) 132-138;
  6. Sugiyama, K

    1. You have access
      Secobarbital-mediated inactivation of rat liver cytochrome P-450b: a mechanistic reappraisal.
      J M Lunetta, K Sugiyama and M A Correia
      Molecular Pharmacology January 1989, 35 (1) 10-17;

T

  1. Thomas, J M

    1. You have access
      Chronic somatostatin treatment induces enhanced forskolin-stimulated cAMP accumulation in wild-type S49 mouse lymphoma cells but not in protein kinase-deficient mutants.
      J M Thomas and B B Hoffman
      Molecular Pharmacology January 1989, 35 (1) 116-124;

V

  1. Vazquez-Padua, M A

    1. You have access
      Enzyme regulatory site-directed drugs: study of the interactions of 5'-amino-2', 5'-dideoxythymidine (5'-AdThd) and thymidine triphosphate with thymidine kinase and the relationship to the stimulation of thymidine uptake by 5'-AdThd in 647V cells.
      M A Vazquez-Padua, K Kunugi and P H Fischer
      Molecular Pharmacology January 1989, 35 (1) 98-104;
  2. Vella-Rountree, L

    1. You have access
      Different agonist-receptor active conformations for rat brain M1 and M2 muscarinic receptors that are separately coupled to two biochemical effector systems.
      M McKinney, D Anderson and L Vella-Rountree
      Molecular Pharmacology January 1989, 35 (1) 39-47;

W

  1. Walsh, M P

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;
  2. Waszczak, B L

    1. You have access
      Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
      R F Cox and B L Waszczak
      Molecular Pharmacology January 1989, 35 (1) 125-131;
  3. Wise, B

    1. You have access
      Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;
  4. Wong, K

    1. You have access
      Effects of gold coordination complexes on neutrophil function are mediated via inhibition of protein kinase C.
      J E Parente, M P Walsh, P R Girard, J F Kuo, D S Ng and K Wong
      Molecular Pharmacology January 1989, 35 (1) 26-33;
  5. Wu, C S

    1. You have access
      Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
      C S Wu and J T Yang
      Molecular Pharmacology January 1989, 35 (1) 85-92;

Y

  1. Yang, J T

    1. You have access
      Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
      C S Wu and J T Yang
      Molecular Pharmacology January 1989, 35 (1) 85-92;
  2. Ye, Q

    1. You have access
      Conformational and steric aspects of phenylethanolamine and phenylethylamine analogues as substrates or inhibitors of phenylethanolamine N-methyltransferase.
      G L Grunewald, Q Ye, D J Sall, K R Criscione and B Wise
      Molecular Pharmacology January 1989, 35 (1) 93-97;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 1
1 Jan 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics